Skip to main content
Top
Published in: European Radiology 10/2022

Open Access 18-08-2022 | Brachytherapy | Oncology

Peritumoral abnormalities on dynamic-enhanced CT after brachytherapy for hepatic malignancies: local progression or benign changes?

Authors: Guanyu Chen, Dechao Jiao, Sheng Peng, Xi Chen, Yanling Zhang, Letao Lin, Zhihui Zhong, Yong Li, Kaihao Xu, Fujun Zhang

Published in: European Radiology | Issue 10/2022

Login to get access

Abstract

Objectives

To determine if dynamic CT can differentiate local progression from radioactive seed-induced peritumoral reaction (RSIPR) after brachytherapy with iodine-125 radioactive seeds (BIRS) for advanced hepatic malignancies.

Methods

Enhanced CT images of seed-implanted lesions between 2006 and 2018 were retrospectively evaluated. Hounsfield units of peritumoral parenchyma were measured and assessed quantitatively. The classification, conversion, consequences, and serological indicators during follow-up were recorded and quantified. Statistical differences were analyzed using a Pearson χ2 test.

Results

RSIPR was observed in 201 of 290 (69.3%) lesions (161 patients; median age, 55 years; range, 26–79 years), while local progression occurred in 53 lesions. The low density of local progression was much lower than that of RSIPR (p < 0.001), and the former did not exhibit iso-/high density in the portal or equilibrium phase. Ring-like enhancement in progressive lesions was also quite different from RSIPR. Local progression rate was lower for lesions with RSIPR than for those without RSIPR (14.9% vs 25.8%; p = 0.03), and their doses were different (397.2 Gy vs 120.3 Gy, p < 0.001).

Conclusions

Radioactive seed-induced peritumoral reaction has characteristic manifestations on CT images, which is associated with a higher dose of lesions and lower local progression rate. Notably, the enhancement pattern of local progression was distinct from RSIPR and was clearly distinguishable on dynamic-enhanced CT.

Key Points

• Radioactive seed-induced peritumoral reaction after brachytherapy with 125 I seeds for liver malignancies has characteristic manifestations on CT images, which is associated with a higher dose of lesions (397.2 Gy vs 120.3 Gy, p < 0.001), as a focal radiation injury.
• Lesions with RSIPR were less likely to develop local progression, while those without RSIPR had a higher rate of local progression (14.9% vs 25.8%; p = 0.03).
• The enhancement pattern of local progression after brachytherapy was distinct from radioactive seed-induced peritumoral reaction and was clearly distinguishable on dynamic-enhanced CT.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249CrossRef Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249CrossRef
2.
go back to reference Brodt P (2016) Role of the microenvironment in liver metastasis: from pre- to prometastatic niches. Clin Cancer Res 22:5971–5982CrossRef Brodt P (2016) Role of the microenvironment in liver metastasis: from pre- to prometastatic niches. Clin Cancer Res 22:5971–5982CrossRef
3.
go back to reference Leporrier J, Maurel J, Chiche L, Bara S, Segol P, Launoy G (2006) A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg 93:465–474CrossRef Leporrier J, Maurel J, Chiche L, Bara S, Segol P, Launoy G (2006) A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg 93:465–474CrossRef
4.
go back to reference Rowcroft A, Loveday BPT, Thomson BNJ, Banting S, Knowles B (2020) Systematic review of liver directed therapy for uveal melanoma hepatic metastases. HPB (Oxford) 22:497–505CrossRef Rowcroft A, Loveday BPT, Thomson BNJ, Banting S, Knowles B (2020) Systematic review of liver directed therapy for uveal melanoma hepatic metastases. HPB (Oxford) 22:497–505CrossRef
5.
go back to reference Sperti C, Pasquali C, Piccoli A, Pedrazzoli S (1997) Recurrence after resection for ductal adenocarcinoma of the pancreas. World J Surg 21:195–200CrossRef Sperti C, Pasquali C, Piccoli A, Pedrazzoli S (1997) Recurrence after resection for ductal adenocarcinoma of the pancreas. World J Surg 21:195–200CrossRef
6.
go back to reference Martinez-Monge R, Nag S, Nieroda CA, Martin EW (1999) Iodine-125 brachytherapy in the treatment of colorectal adenocarcinoma metastatic to the liver. Cancer 85:1218–1225CrossRef Martinez-Monge R, Nag S, Nieroda CA, Martin EW (1999) Iodine-125 brachytherapy in the treatment of colorectal adenocarcinoma metastatic to the liver. Cancer 85:1218–1225CrossRef
7.
go back to reference Nag S, DeHaan M, Scruggs G, Mayr N, Martin EW (2006) Long-term follow-up of patients of intrahepatic malignancies treated with iodine-125 brachytherapy. Int J Radiat Oncol Biol Phys 64:736–744CrossRef Nag S, DeHaan M, Scruggs G, Mayr N, Martin EW (2006) Long-term follow-up of patients of intrahepatic malignancies treated with iodine-125 brachytherapy. Int J Radiat Oncol Biol Phys 64:736–744CrossRef
8.
go back to reference Chen K, Xia Y, Wang H, Xiao F, Xiang G, Shen F (2013) Adjuvant iodine-125 brachytherapy for hepatocellular carcinoma after complete hepatectomy: a randomized controlled trial. PLoS One 8:e57397CrossRef Chen K, Xia Y, Wang H, Xiao F, Xiang G, Shen F (2013) Adjuvant iodine-125 brachytherapy for hepatocellular carcinoma after complete hepatectomy: a randomized controlled trial. PLoS One 8:e57397CrossRef
9.
go back to reference Jiang TA, Deng Z, Tian G, Zhao QY, Wang WL (2016) Efficacy and safety of endoscopic ultrasonography-guided interventional treatment for refractory malignant left-sided liver tumors: a case series of 26 patients. Sci Rep 6:36098CrossRef Jiang TA, Deng Z, Tian G, Zhao QY, Wang WL (2016) Efficacy and safety of endoscopic ultrasonography-guided interventional treatment for refractory malignant left-sided liver tumors: a case series of 26 patients. Sci Rep 6:36098CrossRef
10.
go back to reference Zhu HD, Guo JH, Zhu GY et al (2012) A novel biliary stent loaded with (125)I seeds in patients with malignant biliary obstruction: preliminary results versus a conventional biliary stent. J Hepatol 56:1104–1111CrossRef Zhu HD, Guo JH, Zhu GY et al (2012) A novel biliary stent loaded with (125)I seeds in patients with malignant biliary obstruction: preliminary results versus a conventional biliary stent. J Hepatol 56:1104–1111CrossRef
11.
go back to reference Peng S, Yang QX, Zhang T et al (2014) Lobaplatin-TACE combined with radioactive 125I seed implantation for treatment of primary hepatocellular carcinoma. Asian Pac J Cancer Prev 15:5155–5160CrossRef Peng S, Yang QX, Zhang T et al (2014) Lobaplatin-TACE combined with radioactive 125I seed implantation for treatment of primary hepatocellular carcinoma. Asian Pac J Cancer Prev 15:5155–5160CrossRef
12.
go back to reference Zhu ZX, Wang XX, Yuan KF, Huang JW, Zeng Y (2018) Transarterial chemoembolization plus iodine-125 implantation for hepatocellular carcinoma: a systematic review and meta-analysis. HPB (Oxford) 20:795–802CrossRef Zhu ZX, Wang XX, Yuan KF, Huang JW, Zeng Y (2018) Transarterial chemoembolization plus iodine-125 implantation for hepatocellular carcinoma: a systematic review and meta-analysis. HPB (Oxford) 20:795–802CrossRef
13.
go back to reference Xie S, Wu Z, Zhou L et al (2018) Iodine-125 seed implantation and allogenic natural killer cell immunotherapy for hepatocellular carcinoma after liver transplantation: a case report. Onco Targets Ther 11:7345–7352CrossRef Xie S, Wu Z, Zhou L et al (2018) Iodine-125 seed implantation and allogenic natural killer cell immunotherapy for hepatocellular carcinoma after liver transplantation: a case report. Onco Targets Ther 11:7345–7352CrossRef
14.
go back to reference Nath R, Anderson LL, Luxton G, Weaver KA, Williamson JF, Meigooni AS (1995) Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine. Med Phys 22:209–234CrossRef Nath R, Anderson LL, Luxton G, Weaver KA, Williamson JF, Meigooni AS (1995) Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine. Med Phys 22:209–234CrossRef
15.
go back to reference Nag S, Bice W, DeWyngaert K, Prestidge B, Stock R, Yu Y (2000) The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. Int J Radiat Oncol Biol Phys 46:221–230CrossRef Nag S, Bice W, DeWyngaert K, Prestidge B, Stock R, Yu Y (2000) The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. Int J Radiat Oncol Biol Phys 46:221–230CrossRef
16.
go back to reference Lencioni R, Llovet JM (2010) Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 30:52–60CrossRef Lencioni R, Llovet JM (2010) Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 30:52–60CrossRef
17.
go back to reference Llovet JM, Lencioni R (2020) mRECIST for HCC: performance and novel refinements. J Hepatol 72:288–306CrossRef Llovet JM, Lencioni R (2020) mRECIST for HCC: performance and novel refinements. J Hepatol 72:288–306CrossRef
18.
go back to reference Takamatsu S, Kozaka K, Kobayashi S et al (2018) Pathology and images of radiation-induced hepatitis: a review article. Jpn J Radiol 36:241–256CrossRef Takamatsu S, Kozaka K, Kobayashi S et al (2018) Pathology and images of radiation-induced hepatitis: a review article. Jpn J Radiol 36:241–256CrossRef
19.
go back to reference Toesca DAS, Ibragimov B, Koong AJ, Xing L, Koong AC, Chang DT (2018) Strategies for prediction and mitigation of radiation-induced liver toxicity. J Radiat Res 59:i40–i49CrossRef Toesca DAS, Ibragimov B, Koong AJ, Xing L, Koong AC, Chang DT (2018) Strategies for prediction and mitigation of radiation-induced liver toxicity. J Radiat Res 59:i40–i49CrossRef
20.
go back to reference Herfarth KK, Hof H, Bahner ML et al (2003) Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors. Int J Radiat Oncol Biol Phys 57:444–451CrossRef Herfarth KK, Hof H, Bahner ML et al (2003) Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors. Int J Radiat Oncol Biol Phys 57:444–451CrossRef
21.
go back to reference Koay EJ, Owen D, Das P (2018) Radiation-induced liver disease and modern radiotherapy. Semin Radiat Oncol 28:321–331CrossRef Koay EJ, Owen D, Das P (2018) Radiation-induced liver disease and modern radiotherapy. Semin Radiat Oncol 28:321–331CrossRef
22.
go back to reference Munoz-Schuffenegger P, Ng S, Dawson LA (2017) Radiation-induced liver toxicity. Semin Radiat Oncol 27:350–357CrossRef Munoz-Schuffenegger P, Ng S, Dawson LA (2017) Radiation-induced liver toxicity. Semin Radiat Oncol 27:350–357CrossRef
23.
go back to reference Kimura T, Takahashi S, Takahashi I et al (2015) The time course of dynamic computed tomographic appearance of radiation injury to the cirrhotic liver following stereotactic body radiation therapy for hepatocellular carcinoma. PLoS One 10:e0125231CrossRef Kimura T, Takahashi S, Takahashi I et al (2015) The time course of dynamic computed tomographic appearance of radiation injury to the cirrhotic liver following stereotactic body radiation therapy for hepatocellular carcinoma. PLoS One 10:e0125231CrossRef
24.
go back to reference Sanuki-Fujimoto N, Takeda A, Ohashi T et al (2010) CT evaluations of focal liver reactions following stereotactic body radiotherapy for small hepatocellular carcinoma with cirrhosis: relationship between imaging appearance and baseline liver function. Br J Radiol 83:1063–1071CrossRef Sanuki-Fujimoto N, Takeda A, Ohashi T et al (2010) CT evaluations of focal liver reactions following stereotactic body radiotherapy for small hepatocellular carcinoma with cirrhosis: relationship between imaging appearance and baseline liver function. Br J Radiol 83:1063–1071CrossRef
25.
go back to reference Chiou SY, Lee RC, Chi KH, Chia-Hsien Cheng J, Chiang JH, Chang CY (2001) The triple-phase CT image appearance of post-irradiated livers. Acta Radiol 42:526–531CrossRef Chiou SY, Lee RC, Chi KH, Chia-Hsien Cheng J, Chiang JH, Chang CY (2001) The triple-phase CT image appearance of post-irradiated livers. Acta Radiol 42:526–531CrossRef
26.
go back to reference Ricke J, Seidensticker M, Lüdemann L et al (2005) In vivo assessment of the tolerance dose of small liver volumes after single-fraction HDR irradiation. Int J Radiat Oncol Biol Phys 62:776–784CrossRef Ricke J, Seidensticker M, Lüdemann L et al (2005) In vivo assessment of the tolerance dose of small liver volumes after single-fraction HDR irradiation. Int J Radiat Oncol Biol Phys 62:776–784CrossRef
27.
go back to reference Kimura T, Takahashi S, Kenjo M et al (2013) Dynamic computed tomography appearance of tumor response after stereotactic body radiation therapy for hepatocellular carcinoma: how should we evaluate treatment effects? Hepatol Res 43:717–727CrossRef Kimura T, Takahashi S, Kenjo M et al (2013) Dynamic computed tomography appearance of tumor response after stereotactic body radiation therapy for hepatocellular carcinoma: how should we evaluate treatment effects? Hepatol Res 43:717–727CrossRef
28.
go back to reference Yang Q, Peng S, Wu J et al (2015) Spectral CT with monochromatic imaging and metal artifacts reduction software for artifacts reduction of 125I radioactive seeds in liver brachytherapy. Jpn J Radiol 33:694–705CrossRef Yang Q, Peng S, Wu J et al (2015) Spectral CT with monochromatic imaging and metal artifacts reduction software for artifacts reduction of 125I radioactive seeds in liver brachytherapy. Jpn J Radiol 33:694–705CrossRef
Metadata
Title
Peritumoral abnormalities on dynamic-enhanced CT after brachytherapy for hepatic malignancies: local progression or benign changes?
Authors
Guanyu Chen
Dechao Jiao
Sheng Peng
Xi Chen
Yanling Zhang
Letao Lin
Zhihui Zhong
Yong Li
Kaihao Xu
Fujun Zhang
Publication date
18-08-2022
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 10/2022
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-022-09074-x

Other articles of this Issue 10/2022

European Radiology 10/2022 Go to the issue